Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Denys

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Journal of Clinical Neuro-Ophthalmology|March 1, 1983
Clinical and subclinical oculomotor findings in the Eaton-Lambert syndromeM P Cruciger, B Brown, E H Denys, et al.
Facts, Views & Vision in Obgyn|October 30, 2020
Treatment algorithm in patients with ovarian cancerI Vergote, H Denys, J De Greve, et al.
British Journal of Cancer|July 5, 2001
Tcf-3 expression and beta-catenin mediated transcriptional activation in aggressive fibromatosis (desmoid tumour)S Tejpar, C Li, C Yu, et al.
Diabetologia|May 1, 1982
The risk of diabetic control: a comparison of hospital versus general practice supervisionA Basdevant, D Costagliola, J L Lanöe, et al.
Facts, Views & Vision in Obgyn|July 5, 2022
Homologous recombination repair deficiency (HRD) testing in newly diagnosed advanced-stage epithelial ovarian cancer: A Belgian expert opinionI Vergote, H Denys, S Altintas, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|April 25, 2012
Intensity-modulated arc therapy with cisplatin as neo-adjuvant treatment for primary irresectable cervical cancer. Toxicity, tumour response and outcomeK Vandecasteele, A Makar, R Van den Broecke, et al.
Annals of Neurology|March 1, 1990
Lower motor neuron syndromes defined by patterns of weakness, nerve conduction abnormalities, and high titers of antiglycolipid antibodiesA Pestronk, V Chaudhry, E L Feldman, et al.
British Journal of Cancer|April 1, 2004
Invasion and MMP expression profile in desmoid tumoursH Denys, O De Wever, B Nusgens, et al.
Gynecologic Oncology|October 10, 2013
Evaluation of the quality of the management of cancer of the corpus uteri--selection of relevant quality indicators and implementation in BelgiumJ Werbrouck, G Bouche, E de Jonge, et al.
ESMO Open|May 9, 2026
Efficacy of olaparib in advanced cancers with somatic or germline mutations in BAP1, BARD1, BRIP1 and PALB2S Joris, H Denys, J Collignon, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Journal of Clinical Neuro-Ophthalmology|March 1, 1983
Clinical and subclinical oculomotor findings in the Eaton-Lambert syndromeM P Cruciger, B Brown, E H Denys, et al.
Facts, Views & Vision in Obgyn|October 30, 2020
Treatment algorithm in patients with ovarian cancerI Vergote, H Denys, J De Greve, et al.
British Journal of Cancer|July 5, 2001
Tcf-3 expression and beta-catenin mediated transcriptional activation in aggressive fibromatosis (desmoid tumour)S Tejpar, C Li, C Yu, et al.
Diabetologia|May 1, 1982
The risk of diabetic control: a comparison of hospital versus general practice supervisionA Basdevant, D Costagliola, J L Lanöe, et al.
Facts, Views & Vision in Obgyn|July 5, 2022
Homologous recombination repair deficiency (HRD) testing in newly diagnosed advanced-stage epithelial ovarian cancer: A Belgian expert opinionI Vergote, H Denys, S Altintas, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|April 25, 2012
Intensity-modulated arc therapy with cisplatin as neo-adjuvant treatment for primary irresectable cervical cancer. Toxicity, tumour response and outcomeK Vandecasteele, A Makar, R Van den Broecke, et al.
Annals of Neurology|March 1, 1990
Lower motor neuron syndromes defined by patterns of weakness, nerve conduction abnormalities, and high titers of antiglycolipid antibodiesA Pestronk, V Chaudhry, E L Feldman, et al.
British Journal of Cancer|April 1, 2004
Invasion and MMP expression profile in desmoid tumoursH Denys, O De Wever, B Nusgens, et al.
Gynecologic Oncology|October 10, 2013
Evaluation of the quality of the management of cancer of the corpus uteri--selection of relevant quality indicators and implementation in BelgiumJ Werbrouck, G Bouche, E de Jonge, et al.
ESMO Open|May 9, 2026
Efficacy of olaparib in advanced cancers with somatic or germline mutations in BAP1, BARD1, BRIP1 and PALB2S Joris, H Denys, J Collignon, et al.
Pageof 7